MICHELLE SEIZYS MD NPI 1831192491

NPI Details

Michelle Seizys, MD is an internal medicine in Hastings, NE with 32 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Michelle Seizys, MD NPI is 1831192491. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF NEBRASKA COLLEGE OF MEDICINE
Graduation Year:1994

The provider's business location address is:

2115 N KANSAS AVE
STE 105A
HASTINGS, NE
ZIP 68901-615
Phone: (402) 463-2454
Fax: (402) 463-2450

The NPI 1831192491 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Hemoglobin a1c level (HCPCS:83036)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Automated urinalysis test (HCPCS:81003)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Vitamin d-3 level (HCPCS:82306)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Blood test, clotting time (HCPCS:85610)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Ferritin (blood protein) level (HCPCS:82728)
• Magnesium level (HCPCS:83735)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Amylase (enzyme) level (HCPCS:82150)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Myoglobin (muscle protein) level (HCPCS:83874)
• Creatine kinase (cardiac enzyme) level, mb fraction only (HCPCS:82553)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Troponin (protein) analysis, quantitative (HCPCS:84484)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urine microalbumin (protein) level (HCPCS:82043)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only (HCPCS:93010)
• Uric acid level, blood (HCPCS:84550)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic (HCPCS:G2012)

The enumeration date for this NPI number is 5/27/2005 and was last updated on 1/17/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.